KL-6和SP-D在慢性过敏性肺炎的诊断和管理中的用处
The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis
Tsukasa Okamotoe, Mayumi Fujiie, Haruhiko Furusawae, Kimitake Tsuchiyae, Yasunari Miyazakie, Naohiko Inasee
Background
It is believed that Krebs von den Lungen-6 (KL-6) and surfactant protein D (SP-D) are useful biomarkers for the diagnosis of various types of interstitial lung diseases, including hypersensitivity pneumonitis (HP). The clinical features of chronic HP are similar to those of idiopathic interstitial pneumonias, especially idiopathic pulmonary fibrosis (IPF).
Objective
We sought to clarify the usefulness of serum KL-6 and SP-D for the diagnosis and management of chronic HP.
Methods
We examined serum KL-6 and SP-D levels and retrospectively evaluated the clinical parameters of acute HP (n = 35), chronic HP (n = 57), IPF (n = 54), collagen vascular disease-associated interstitial pneumonia (CVD-IP) (n = 67), and sarcoidosis (n = 47). We analyzed the relations between the two biomarkers and clinical data in chronic HP.
Results
Serum KL-6 and SP-D levels in acute HP (2710 U/ml and 338 ng/ml, median) and chronic HP (1500 U/ml and 264 ng/ml, median) were significantly higher than in IPF, CVD-IP, and sarcoidosis. The area under the curve (AUC) values for serum KL-6 and SP-D between chronic HP and IPF were 0.771 and 0.729, respectively. Serum KL-6 levels in chronic HP were significantly higher during episodes of acute exacerbation than 1 month before acute exacerbation. The serum KL-6 levels had correlations with serum SP-D and the percentage of lymphocytes in bronchoalveolar lavage fluid.
Conclusions
Serum KL-6 and SP-D levels are useful for the diagnosis and management of chronic HP.
respiratory medicine
December 2015Volume 109, Issue 12, Pages 1576–1581
DOI: http://dx.doi.org/10.1016/j.rmed.2015.10.005 |
copyright©金宝搏网站登录技巧 版权所有,未经许可不得复制、转载或镜像
京ICP证120392号 京公网安备110105007198 京ICP备10215607号-1 (京)网药械信息备字(2022)第00160号